491 related articles for article (PubMed ID: 17044021)
1. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
2. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas.
Perren A; Anlauf M; Henopp T; Rudolph T; Schmitt A; Raffel A; Gimm O; Weihe E; Knoefel WT; Dralle H; Heitz PU; Komminoth P; Klöppel G
J Clin Endocrinol Metab; 2007 Mar; 92(3):1118-28. PubMed ID: 17179192
[TBL] [Abstract][Full Text] [Related]
9. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
11. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia type 1.
Agarwal SK
Front Horm Res; 2013; 41():1-15. PubMed ID: 23652667
[TBL] [Abstract][Full Text] [Related]
13. The gene for multiple endocrine neoplasia type 1: recent findings.
Marx SJ; Agarwal SK; Heppner C; Kim YS; Kester MB; Goldsmith PK; Skarulis MC; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree JS; Collins FS; Chandrasekharappa SC
Bone; 1999 Jul; 25(1):119-22. PubMed ID: 10423035
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
16. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
[TBL] [Abstract][Full Text] [Related]
17. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
Lejonklou MH; Barbu A; Stålberg P; Skogseid B
Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.
Lemos MC; Thakker RV
Hum Mutat; 2008 Jan; 29(1):22-32. PubMed ID: 17879353
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of menin in various adrenal tumors. The role of menin in adrenal tumors.
Bhuiyan MM; Sato M; Murao K; Imachi H; Namihira H; Ishida T; Takahara J; Miyauchi A
Cancer; 2001 Sep; 92(6):1393-401. PubMed ID: 11745215
[TBL] [Abstract][Full Text] [Related]
20. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
